University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center Site Number : 132 is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.
Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.
University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center Site Number : 132 has participated in 2 clinical trials.
Therapeutic areas: Chronic Graft-versus-host-disease.
Sponsors: Kadmon, a Sanofi Company.
Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center Site Number : 132 has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center Site Number : 132 has 2 clinical trials on record. Their work covers Chronic Graft-versus-host-disease.
University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center Site Number : 132 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.